Looks Like A Sure Winner
Where have the serious commentators gone? All I see now are these doomsday analysts with their overly dramatized posts.
I'm in for the future dividend. Expect steady recovery quarter on quarter in a challenging loan environment. They are over funded so lots of capital is not being employed. If Q4 earnings are annualized we have a P/E of about 11. If earnings improve, it's your guess for the price of HCG following Q3 2018 results.